Form 4: Aveanna CAO Sells Shares for Tax Obligations

Aveanna Healthcare Holdings' Chief Administrative Officer, Edwin C. Reisz, sold common stock totaling 50,970 shares across three transactions to cover tax obligations from vested equity awards.

Summary

• Edwin C. Reisz, Chief Administrative Officer of Aveanna Healthcare Holdings, Inc. (AVAH), reported sales of common stock.
• The transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
• On December 30, 2025, 16,755 shares were sold at a weighted average price of $8.3556 per share.
• On December 31, 2025, 16,602 shares were sold at a weighted average price of $8.1777 per share.
• On January 2, 2026, 17,613 shares were sold at a weighted average price of $7.8452 per share.
• The total number of shares sold across these three dates is 50,970.
• These sales were conducted to satisfy the reporting person's tax obligation related to the vesting of equity awards.
• Following these transactions, Edwin C. Reisz beneficially owns 1,321,114 shares of common stock.
• The reported beneficial ownership includes 587 shares acquired under the Registrant's Employee Stock Purchase Plan (ESPP) in July 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling reduces direct ownership, these sales are explicitly for tax obligations related to vested equity awards and were conducted under a pre-arranged 10b5-1 plan, which is a routine and expected event for executives and does not necessarily reflect a change in management's outlook on the company's fundamentals.

Positives

• The transactions were executed under a Rule 10b5-1(c) plan, indicating pre-scheduled sales not based on immediate market timing.
• The reporting person acquired 587 shares through the Employee Stock Purchase Plan (ESPP) in July 2025, demonstrating continued participation in employee ownership programs.

Negatives

• The sales resulted in a reduction of direct beneficial ownership by a key executive, totaling 50,970 shares.
• The weighted average sale price for the shares declined across the three transaction dates, from $8.3556 to $7.8452.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing is a routine insider transaction report and does not provide information directly related to broader industry trends or competitive landscape within the healthcare services sector.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, which is a common occurrence for tax purposes and generally not indicative of a change in company fundamentals.
• Employees: No direct impact on employees, though the ESPP acquisition shows continued employee participation in stock ownership.

Key Dates

Recommendation

The filing details routine, non-discretionary sales by an executive to cover tax obligations from vested equity awards, executed under a 10b5-1 plan. Such transactions do not typically signal a change in the company's fundamental value or management's long-term confidence, thus a 'hold' recommendation is appropriate as there is no new information to warrant a change in investment thesis.

Keywords

Aveanna Healthcare Holdings, AVAH, Form 4, Insider Transaction, Stock Sale, Equity Awards, Tax Obligation, Edwin C. Reisz, 10b5-1 Plan